Metformin Hydrochloride Aspire

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformin Hydrochloride Aspire (Metformin Hydrochloride)

Q: What is Metformin Hydrochloride Aspire used for?

Metformin Hydrochloride Aspire is used to improve blood glucose control in adults with type 2 diabetes mellitus. It may also be prescribed for prediabetes and polycystic ovary syndrome to address insulin resistance.

Q: How does Metformin Hydrochloride work?

Metformin works by activating AMP‑activated protein kinase, which reduces glucose production in the liver and increases insulin‑mediated glucose uptake in muscle and fat tissues, thereby lowering blood sugar levels without stimulating insulin release.

Q: What is the usual dose of Metformin Hydrochloride Aspire?

The specific dose and dosing schedule are determined by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions precisely.

Q: Is Metformin Hydrochloride Aspire safe during pregnancy or breastfeeding?

Metformin Hydrochloride is classified as Pregnancy Category B, indicating that animal studies have not shown risk and there are no adequate human studies. It may be used during pregnancy or lactation if the benefits outweigh potential risks, as decided by the treating physician.

Q: How do I order Metformin Hydrochloride Aspire from GNH India?

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Q: How does Metformin Hydrochloride compare with other antidiabetic drugs?

Metformin belongs to the biguanide class and is often first‑line therapy for type 2 diabetes because it improves insulin sensitivity without causing weight gain. Compared with sulfonylureas, it has a lower risk of hypoglycaemia, and unlike insulin, it is administered orally.

Q: What are the storage and handling requirements for Metformin Hydrochloride Aspire?

Store the product at room temperature, below 25 °C, in the original packaging. Protect it from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Q: How is Metformin Hydrochloride Aspire administered?

Metformin Hydrochloride Aspire is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless otherwise directed by a healthcare professional.

Q: What are the most serious risks associated with Metformin Hydrochloride Aspire?

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or acute medical illnesses. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Q: Who should not use Metformin Hydrochloride Aspire?

Metformin should be avoided in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or in those who have experienced lactic acidosis while on the drug.

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Aspire, is a biguanide presented as an oral formulation for oral use. It is indicated for the management of type 2 diabetes mellitus in adults, helping to control elevated blood glucose levels.

GNH India supplies Metformin Hydrochloride Aspire as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements.

Manufacturer / TM Owner

Aspire Pharma Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformin Hydrochloride is used primarily in the management of disorders related to glucose metabolism and insulin resistance.

Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial blood glucose levels.
Prediabetes (impaired fasting glucose): helps delay progression to overt diabetes through improved insulin sensitivity.
Polycystic ovary syndrome: reduces insulin resistance and may aid in restoring ovulatory function.

How It Works

Metformin Hydrochloride reduces hepatic gluconeogenesis and increases peripheral glucose uptake by activating AMP‑activated protein kinase (AMPK). This leads to decreased hepatic glucose output and enhanced insulin‑mediated glucose utilization in muscle and adipose tissue, thereby lowering circulating blood glucose concentrations without directly stimulating insulin secretion.

Side Effects

Metformin Hydrochloride is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects

Nausea: mild to moderate gastrointestinal discomfort.
Diarrhoea: frequent loose stools, especially during treatment initiation.
Abdominal discomfort: cramping or bloating.
Metallic taste: transient alteration in taste perception.
Loss of appetite: reduced desire to eat.
Flatulence: increased intestinal gas.

Serious or Rare Side Effects

Lactic acidosis: rare but potentially fatal metabolic disturbance.
Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
Hepatic failure: rare liver dysfunction.
Hypoglycaemia: uncommon when used alone, may occur with other antidiabetic agents.
Vitamin B12 deficiency: long‑term therapy may reduce B12 absorption.

Precautions & Warnings

Metformin Hydrochloride requires careful assessment and monitoring to minimise risks.

Renal function assessment: avoid use in severe renal impairment (eGFR <30 mL/min/1.73 m²).
Hepatic impairment: use with caution in patients with liver disease due to lactic acidosis risk.
Alcohol consumption: limit intake as excessive alcohol increases lactic acidosis risk.
Pregnancy safety: classified Category B; benefits should outweigh potential risks.
Vitamin B12 monitoring: consider periodic assessment during prolonged therapy.
Store at room temperature: keep in the original packaging, protect from moisture and heat.

Avoid Interactions

Metformin Hydrochloride may interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

Iodinated contrast agents: can precipitate acute renal failure and increase lactic acidosis risk.
Cimetidine: may raise metformin plasma concentrations.
Alcohol excess: potentiates lactic acidosis.
Carbamazepine: may reduce metformin effectiveness.
Nitrates: concurrent use may increase risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

Sulfonylureas: increased risk of hypoglycaemia.
Beta‑blockers: may mask hypoglycaemia symptoms.
ACE inhibitors or ARBs: monitor renal function and electrolytes.
Warfarin: may enhance anticoagulant effect, requiring INR monitoring.
Diuretics: can affect renal clearance of metformin.

Frequently Asked Questions

Metformin Hydrochloride Aspire is used to improve blood glucose control in adults with type 2 diabetes mellitus. It may also be prescribed for prediabetes and polycystic ovary syndrome to address insulin resistance.

Metformin works by activating AMP‑activated protein kinase, which reduces glucose production in the liver and increases insulin‑mediated glucose uptake in muscle and fat tissues, thereby lowering blood sugar levels without stimulating insulin release.

The specific dose and dosing schedule are determined by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions precisely.

Metformin Hydrochloride is classified as Pregnancy Category B, indicating that animal studies have not shown risk and there are no adequate human studies. It may be used during pregnancy or lactation if the benefits outweigh potential risks, as decided by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin belongs to the biguanide class and is often first‑line therapy for type 2 diabetes because it improves insulin sensitivity without causing weight gain. Compared with sulfonylureas, it has a lower risk of hypoglycaemia, and unlike insulin, it is administered orally.

Store the product at room temperature, below 25 °C, in the original packaging. Protect it from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Metformin Hydrochloride Aspire is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless otherwise directed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or acute medical illnesses. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformin should be avoided in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or in those who have experienced lactic acidosis while on the drug.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 05 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.